The role of circulating protein and metabolite biomarkers in the development of pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis.
Swati KumarRalph J SantosAndrew J McGuiganUrvashi SinghPeter JohnsonAndrew T KunzmannRichard C TurkingtonPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
Glucose and PLP levels are associated with PDAC risk. More prospective studies are required to identify biomarkers for early detection.